Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > [S(R)]-N-[(S)-(3-(di-tert-butylphosphanyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)(9,10-dihydro-9,10-[1,2]benzenoanthracen-2-yl)methyl]-N,2-dimethylpropane-2-sulfinamide
[S(R)]-N-[(S)-(3-(di-tert-butylphosphanyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)(9,10-dihydro-9,10-[1,2]benzenoanthracen-2-yl)methyl]-N,2-dimethylpropane-2-sulfinamide structure, CAS 2A-2194397

[S(R)]-N-[(S)-(3-(di-tert-butylphosphanyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)(9,10-dihydro-9,10-[1,2]benzenoanthracen-2-yl)methyl]-N,2-dimethylpropane-2-sulfinamide

CAS Number2A-2194397

Synonyms

Molecular FormulaC48H62NOPS

Molecular Weight732.1

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-2194397 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 2A-2194397 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number2A-2194397
Catalog No.2A-2194397
Molecular FormulaC48H62NOPS
Molecular Weight732.1
PubChem ID489262299
InChIInChI=1S/C48H62NOPS/c1-44(2,3)51(45(4,5)6)40-29-39-38(47(10,11)25-26-48(39,12)13)28-37(40)43(49(14)52(50)46(7,8)9)30-23-24-35-36(27-30)42-33-21-17-15-19-31(33)41(35)32-20-16-18-22-34(32)42/h15-24,27-29,41-43H,25-26H2,1-14H3/t41?,42?,43-,52+/m0/s1
InChI KeyWJYNDFXKXKWTOD-DKERJAGPSA-N
Related Products in Pharmaceutical Intermediates
[S(R)]-N-[(R)-[3,5-Di-tert-butyl-4-methoxyphenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-N,2-dimethyl-2-propanesulfinamide2A-21943902A-2194390
[S(R)]-N-[(S)-[3,5-Bis(trifluoromethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-N,2-dimethyl-2-propanesulfinamide2A-21943912A-2194391
[S(R)]-N-[(R)-[1,1':3',1''-terphenyl]-5'-yl(2-(diphenylphosphanyl) phenyl)methyl]-2-methylpropane-2-sulfinamide2A-21943942A-2194394
[S(R)]-N-(anthracen-9-ylmethyl)-N-((S)-(2-(dicyclohexylphosphanyl)phenyl)(naphthalen-1-yl)methyl)-2-methylpropane-2-sulfinamide2A-21943952A-2194395
[S(R)]-N-[(S)-[2-(Diadamantanphosphino)phenyl]methyl]-4,5-dimethoxyphenyl)(phenyl)methyl]-N,2-dimethylpropane-2-sulfinamide2A-21943962A-2194396
[S(R)]-N-[(S)-(5-(diphenylphosphanyl)-9,9-dimethyl-9H-xanthen-4-yl)(2-isopropylphenyl)methyl]-2-methylpropane-2-sulfinamide2A-21943982A-2194398
[S(R)]-N-[(S)-[1,1'-biphenyl]-4-yl(5-(diphenylphosphanyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl]-2-methylpropane-2-sulfinamide2A-21943992A-2194399
[S(R)]-N-[(S)-2-(diphenylphosphanyl)-1-(2-((triisopropylsilyl)oxy)phenyl)ethyl]-2-methylpropane-2-sulfinamide2A-21944002A-2194400
[S(R)]-N-((S)-1-(2-(di-p-tolylphosphanyl)phenyl)-2-(diphenylphosphanyl)ethyl)-2-methylpropane-2-sulfinamide2A-21944012A-2194401
N-[(S)-1-((r)-2-(anthracen-9-yl)phenyl)-2-(diphenylphosphanyl)ethyl]-3,5-bis(trifluoromethyl)benzamide2A-21944022A-2194402
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA